Form 8-K - Current report:
SEC Accession No. 0000898432-23-000132
Filing Date
2023-02-28
Accepted
2023-02-28 17:15:30
Documents
2
Period of Report
2023-02-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 20704
2 exh99-1.htm EX-99.1 130928
  Complete submission text file 0000898432-23-000132.txt   152713
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41390 | Film No.: 23687203
SIC: 6770 Blank Checks